5-hydroxy-benzothiazole derivatives having beta-2-adrenoreceptor agonist activity

Details for Australian Patent Application No. 2005308909 (hide)

International Classifications

Event Publications

24 May 2007 PCT application entered the National Phase

PCT publication WO2006/056471 Priority application(s): WO2006/056471

21 June 2007 Amendment Made

The nature of the amendment is: Amend the invention title to read 5-hydroxy-benzothiazole derivatives having beta-2-adrenoreceptor agonist activity

27 August 2009 Application Accepted

Published as AU-B-2005308909

24 December 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.